Jinteki
Jinteki began its roots in pharmacy starting from the nineteenth century as a conservative company resistant to change. The megacorporation had seen a major upheaval in the last twenty years, the company seeing more change than its previous two hundred years of operation. The company’s change began with the appointment of Chairman Satoshi Hiro, a young executive at the time and was considered to be an outsider at the time. Satoshi Hiro began as a lab contractor and was instrumental in discovering the Accelerated In Vitro Maturation process that would allow the company to produce clones faster and cheaper than its competitors in Haas-Bioroid could manufacture their Bioroids. Within a short amount of time, the company found itself in a tight race with the European megacorporation to dominate the ‘labour solutions’ market.
Another of the drastic changes to the company was moving its headquarters from Neo Tokyo to New Angeles, causing several internal shifts in the company that required restructuring to accommodate its sudden growth. The company would find itself in the Nihongai District of the city, bringing much change to the city itself after its relocation. Those loyal to Satoshi made the move and the others would find their influence in the company drastically reduced.
Jinteki products are used around the world, namely in its genetic manipulation that allowed its crops to be grown all around the world in tall standing agroplex structures. The company advances have also paved the way for modern genetic modification (G-Mod) to become commonplace in the world, allowing for changes both cosmetic and drastic previously impossible in humanity. The teacup giraffes and elephants made by Jinteki have found themselves in the possession of celebrities, making them a hot commodity and sought-after status symbol among the masses. Its core pharmaceutical roots have kept the company at the forefront of medical technology with its production of organ replacements and life-extending supplements.
Thanks to its discovered Accelerated In Vitro Maturation process, the company is able to grow full-fledged adult clones in a few weeks. During the intricate process, its labs are able to make alterations to the clone’s genetics to make them more than human and purpose them for their destined tasks. After clones are decanted from their tank, they undergo strict training and conditioning as well as a thorough evaluation before being released to the public. The Henry line was made for strenuous labour, capable of working in dangerous conditions for up to eighteen hours a day with its heightened bone density and increased muscles as its defining features. The Tenma line was made for driving and piloting, they are 75% less likely to be the cause of an accident compared to a human. Jinteki is also able to create clone lines for the exact needs of their clients and continue to do so to keep up with their direct competitors at Haas-Bioroid. The Molloy line was created exclusively for the Mother Molloy chain of restaurants to ensure the quality of service and their foods remain the same all around the world. Housing, food, and fashion are some additional overheads associated with owning clones but the general populace is more receptive to the more human-like clone 'androids'.
Despite the drastic changes in Jinteki brought by Chairman Satoshi Hiro, much of the megacorporation’s sentiments are still old-fashioned. The company foundation is still rather insular, often favouring seniority when it comes to promotions.
Industries: Clones, Genetic Engineering, Pharmaceuticals, Agriculture, Brain Mapping
Subsidiaries: Harmony Medtech, Industry Genomics, Jinteki Biotech, Chronos Protocol, Nisei Division, AgInfusion
Chairman Satoshi Hiro